Quarterly report [Sections 13 or 15(d)]

STOCKHOLDERS??? EQUITY

v3.25.4
STOCKHOLDERS’ EQUITY
 6 Months Ended
Dec. 31, 2025
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 13 - STOCKHOLDERS’ EQUITY

 

During the three and six months ended December 31, 2025, the Company issued 11,883 and 19,464 shares of common stock, respectively, to the independent Board of Directors as part of their board compensation. The grant date fair value was $36,000 and $72,000, respectively, and was recorded as compensation expense in the accompanying consolidated financial statements.

 

During the three and six months ended December 31, 2025, the Company issued 7,419 and 13,280 shares of common stock to a consultant pursuant to the terms of his consultancy agreement. The grant date fair value of the shares was $25,000 and $50,000, respectively, and was recorded as compensation expense in the accompanying consolidated financial statements.

 

During the six months ended December 31, 2025, the Company issued 20,000 shares of common stock to employees pursuant to the terms of their employment agreements. The grant date fair value was $84,400 and was recorded as compensation expense in the accompanying consolidated financial statements.

 

 

NETSOL TECHNOLOGIES, INC.

Notes to Condensed Consolidated Financial Statements

December 31, 2025

(Unaudited)

 

Stock Grants

 

The following table summarizes stock grants awarded as compensation:

 

    # Number of shares     Weighted Average Grant Date Fair Value ($)  
Unvested, June 30, 2025     -     $ -  
Granted     52,744     $ 3.91  
Vested     (52,744 )   $ 3.91  
Unvested, December 31, 2025     -     $ -  

 

For the three and six months ended December 31, 2025, the Company recorded compensation expense of $61,000 and $206,400, respectively. For the three and six months ended December 31, 2024, the Company recorded compensation expense of $39,750 and $79,500, respectively. The weighted average grant date fair value is determined by the Company’s closing stock price on the grant date.